The formation of insoluble amyloid fibrils is associated with an array of devastating human diseases. Dialysis-related amyloidosis (DRA) is a severe complication of hemodialysis that results in the progressive destruction of the bones and joints. Elevated concentrations of b 2 -microglobulin (b 2 m) in the serum of subjects on hemodialysis promote the formation of amyloid fibrils in the osteoarticular tissues, but the cellular basis for the destruction of these tissues in DRA is poorly understood. In this study we performed a systematic analysis of the interaction of monomeric and fibrillar b 2 m with primary human cells of the types present in the synovial joints of subjects with DRA. Building upon observations that macrophages infiltrate b 2 m amyloid deposits in vivo we demonstrate that monocytes, the precursors of macrophages, cannot degrade b 2 m fibrils, and that both monomeric b 2 m and fibrillar b 2 m are cytotoxic to these cells. b 2 m fibrils also impair the formation of bone resorbing osteoclasts from monocytes and reduce the viability of osteoblasts, the cell type that produces bone. As a consequence, we predict that b 2 m amyloid will disrupt the remodelling of the bone, which is critical for the maintenance of this tissue. Moreover, we show that b 2 m fibrils reduce the viability of chondrocytes, rationalizing the loss of cartilage in DRA.
Introduction
The formation of insoluble amyloid fibrils is associated with a spectrum of devastating human diseases, many of which are characterised by tissue destruction [1] . One such disorder is dialysis-related amyloidosis (DRA), a debilitating complication of long-term hemodialysis [2, 3] . The culprit protein of DRA is b 2 -microglubulin (b 2 m) [4, 5] , the non-covalent light-chain of cell surface major histocompatibility complex (MHC) class I molecules [6] . Upon dissociation from MHC molecules, b 2 m is normally removed from the bloodstream by the kidneys [6] . The normal serum concentration of b 2 m is 1-3 mg/ml but, in end stage renal disease, neither the kidney nor the dialysis membrane can efficiently remove b 2 m from the circulation and serum levels increase by up to 60 fold and can exceed 100 mg/ml [2, 3, 7] . At these elevated concentrations, b 2 m forms amyloid fibrils in the osteoarticular tissues resulting in arthropathy, cartilage destruction, bone cysts leading to pathologic fractures, carpal tunnel syndrome and spondyloarthropathy [2] [3] [4] [5] [6] 8, 9] . b 2 m fibril formation is promoted by collagen and the glycosaminoglycans (GAGs) chondroitin-sulfate and heparin [10] [11] [12] [13] [14] . Collagen and chondroitin-sulfate are abundant in osteoarticular tissues, rationalizing the deposition of b 2 m amyloid at these sites, whereas heparin is an anti-coagulant used in hemodialysis. b 2 m lacking the N-terminal six residues of the mature protein (DN6b 2 m) constitutes #30% of the b 2 m in ex vivo DRA amyloid [15] . Unlike full-length wild type (WT) b 2 m, DN6b 2 m forms amyloid fibrils de novo at neutral pH in vitro, a process that is enhanced by GAGs [12, 13, [16] [17] [18] . DN6b 2 m fibrils also cross-seed fibril formation with WT b 2 m and can convert WT b 2 m into an amyloidogenic state, suggesting that DN6b 2 m could initiate fibril formation in vivo [17, 18] .
In contrast to the increasing knowledge of the mechanism of b 2 m fibril assembly in vitro [6, 19] , how b 2 m amyloid causes skeletal morbidity in DRA is poorly understood. Macrophages infiltrate b 2 m amyloid deposits and have been implicated in the development of symptomatic DRA [20] [21] [22] . Cells of the monocyte/ macrophage lineage are precursors of osteoclasts, which may be responsible for osteolytic lesions in DRA [23] [24] [25] [26] [27] . Indeed, human b 2 m has been shown to promote osteoclastogenesis from murine macrophages [28] , but whether monomeric or fibrillar b 2 m species promote human osteoclast formation is not known. Since b 2 m fibrils generated in vitro are cytotoxic to some cultured cell lines [29] , b 2 m amyloid formation could also cause bone and joint destruction via cytotoxicity to cell types that are responsible for the maintenance of the osteoarticular tissues.
Herein we perform a systematic comparison of the effects of monomeric and fibrillar b 2 m on primary human cells relevant to the pathology of DRA (monocytes, osteoblasts and chondrocytes). Our data do not support a role for monomeric or fibrillar b 2 m in osteoclast formation by human monocytes, but instead show that b 2 m monomer and fibril preparations are cytotoxic to monocytes, osteoblasts and chondrocytes and hence b 2 m cytotoxicity may be an important factor in the bone and joint destruction associated with DRA.
Results
Generation of b 2 m fibrils in vitro at a physiologically relevant pH Recombinant human WT b 2 m and DN6b 2 m were expressed in E. coli and purified [12, 30, 31] . Size-exclusion chromatography (SEC) confirmed that both proteins are predominantly monomeric at pH 7.3 ($98% of WT b 2 m; ,96% of DN6b 2 m), although ,4% of DN6b 2 m was dimeric (Fig. 1A and B) . Neither protein was recognized by the A11 or WO1 antibodies (Fig. 1C) , which bind generic epitopes in cytotoxic oligomers and amyloid fibrils, respectively [32, 33] .
To generate b 2 m fibrils at a physiologically relevant pH, and within an experimentally tractable timescale, fibrils generated at pH 2 from WT b 2 m were fragmented to produce seeds that were then extended with DN6b 2 m monomer at pH 7.3 in the presence of heparin [12] . The resultant fibrils were not recognized by the A11 antibody, were recognized by the WO1 antibody (Fig. 1C) ; bound the amyloid specific dye thioflavin-T (Fig. 1D) and exhibited a long straight morphology when visualized by negative stain transmission electron microscopy (TEM) (Fig. 1E ) reminiscent of ex vivo b 2 m amyloid [34] [35] [36] . Moreover, we have shown previously with Fourier transform infrared spectroscopy that fibrils elongated from WT b 2 m seeds at pH 7 closely resemble ex vivo b 2 m amyloid [36] . Fibrils formed from seeds elongated with a 1:9 mixture of DN6b 2 m and 5-(and -6)-carboxytetramethylrhodamine-SE (TMR) labelled DN6b 2 m also had the characteristic features of amyloid (Fig. 1C, D and F) .
Human monocytes internalize, but do not degrade, b 2 m fibrils
The macrophages that infiltrate b 2 m amyloid plaques are present around blood vessels consistent with these cells being derived from peripheral blood monocytes [20, 37] . We, therefore, investigated whether these cells could play a protective role in DRA via the degradation of b 2 m fibrils. CD14 + monocytes isolated from peripheral blood were cultured in the presence of macrophage colony stimulating factor (M-CSF), whereupon they become adherent and develop a macrophage-like morphology. These cells were incubated with either TMR-labelled monomeric DN6b 2 m or TMR-labelled b 2 m fibrils. Prior to imaging by confocal microscopy the cells were incubated with LysoTracker green, a fluorescent probe that accumulates in acidic intracellular compartments. After 24 hours, both monomer and fibrils were internalized and co-localized with Lysotracker green in punctate structures ( Fig. 2A and B) . The smaller puncta stained by Lysotracker green are characteristic of lysosomes, whereas the larger punctate structures that are most prominent in cells incubated with fibrils may correspond to acidified phagosomes. Indeed, this would be consistent with electron microscopy studies of ex vivo DRA amyloid, in which macrophages were shown to phagocytose b 2 m amyloid [38] .
After incubation for a further 24 hours in the absence of extracellular TMR-labelled monomeric DN6b 2 m or fibrils, a pronounced decrease in intracellular fluorescence was observed for cells that had internalized monomeric protein ( Fig. 2A and C) . In contrast only a modest reduction in intracellular fluorescence occurred in cells that had internalized b 2 m fibrils ( Fig. 2B and D) . Thus monocytes internalize and traffic both b 2 m monomer and fibrils to acidic vesicles, but only the monomeric protein is degraded efficiently. The inability of these phagocytic cells to degrade b 2 m fibrils would allow amyloid deposition to proceed unchecked in the synovial joints of subjects with DRA.
Monomeric and fibrillar b 2 m do not promote osteoclast formation
In addition to forming macrophages, monocytes can differentiate into bone resorbing osteoclasts [24] [25] [26] . Since primary human monocytes interact with both monomeric and fibrillar b 2 m (Fig. 2) , and human b 2 m monomer has been shown to stimulate osteoclast formation from murine macrophages [28] , we next examined whether either monomeric or fibrillar b 2 m can promote osteoclast formation from human monocytes. Osteoclasts are defined as large multinucleate cells, which express high levels of tartrate-resistant acid phosphatase (TRAP) and can resorb artificial bone substrates [24] [25] [26] ; hence each of these characteristics were used to monitor osteoclast formation.
In a control experiment, monocytes were incubated with receptor activator of nuclear factor-K ligand (RANKL), a cytokine that promotes osteoclast formation [24] [25] [26] . After 14 days there were abundant large ($20 mm) cells, which stained positive (dark pink) for TRAP in centrally located intracellular vesicles (Fig. 3A) . Many of the cells were multinucleate, as visualised by hematoxylin staining, and they were able to resorb the majority (,70%) of an artificial bone substrate ( Fig. 3A and   B ). This confirmed that under the culture conditions used in this study osteoclasts form in 14 days. In contrast, when cells were incubated with buffer, DN6b 2 m monomer or WT b 2 m monomer, at concentrations (10 and 100 mg/ml) that span those observed in the serum of subjects with DRA [2, 3, 7] , only a small number of multinucleate, TRAP positive cells were formed, and little of the artificial bone substrate was resorbed (,5%) ( Fig. 3A and B) indicating that neither WT b 2 m nor DN6b 2 m monomeric proteins promote the differentiation of human monocytes into osteoclasts.
When monocytes were incubated with 10 mg/ml b 2 m fibrils very few large multinucleate cells were formed and there was limited resorption of the artificial bone substrate ( Fig. 3A and B) , thus demonstrating that b 2 m fibrils do not promote osteoclast formation. Interestingly many cells did, however exhibit a dramatic increase in TRAP positive vesicles, giving them a dark pink appearance after staining for the enzyme (Fig. 3A) . Elevated TRAP expression has also been observed in pulmonary alveolar macrophages that have phagocytosed microbes and other particles [39] ; therefore TRAP could be increased in monocytes due to the internalization of b 2 m fibrils. Indeed after only 24 hours incubation with b 2 m fibrils, the level of TRAP expression was increased markedly (Fig. 3C ).
An alternative possibility for the observed increase in TRAP expression was that b 2 m fibrils may provide a partial osteoclastogenic signal that synergizes with other signalling molecules to promote the formation of mature osteoclasts. In vivo osteoclastogenesis is promoted by RANKL, a cytokine expressed on the surface of osteoblasts [24] [25] [26] , this molecule was absent from all but the positive control cultures. We, therefore, examined whether b 2 m fibrils act in synergy with RANKL to promote osteoclast formation. Monocytes were incubated with increasing concentra- tions of RANKL in either the presence or absence of 10 mg/ml b 2 m fibrils and osteoclast function assessed by measuring resoprtion of the artificial bone substrate. As expected when monocytes were incubated with RANKL alone the number of osteoclasts formed and resorption of the artificial bone substrate increased as the concentration of this cytokine was increased ( Fig. 4A and B) . However, when cells were incubated with RANKL and b 2 m fibrils, a reduction in resorption of the artificial bone substrate was observed relative to cells incubated with RANKL alone (Fig. 4A and B) . Thus although b 2 m fibrils increase TRAP expression they do not promote osteoclast formation, instead b 2 m fibrils reduce RANKL-dependent osteoclast formation.
b 2 m fibrils are cytotoxic to monocytes, osteoblasts and chondrocytes
Previously we have shown that b 2 m fibrils are cytotoxic to the murine macrophage cell line RAW 264.7 [29] . We therefore investigated whether b 2 m fibrils are also cytotoxic to primary human monocytes. Using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay, a pronounced and significant reduction in cell viability was observed for monocytes incubated with 10 mg/ml b 2 m fibrils ( Fig. 5A and S1A). By contrast to the fibrils, 10 mg/ml of DN6b 2 m and WT b 2 m had a minimal effect on the viability of monocytes (Fig. 5A , 5B, S1A and S1B). Thus fibrils are more cytotoxic than monomeric b 2 m, which is consistent with our previous study of the effect of monomeric and fibrillar b 2 m on the viability of cell lines [29] . b 2 m fibril cytotoxicity may contribute to the failure of monocytes to degrade b 2 m fibrils and could also be responsible for the observed reduction in ostoeclast formation, as monocyte death would prevent these cells from fusing together to form osteoclasts. However, at 100 mg/ml, b 2 m fibrils reduced cell viability by ,40%, as did the monomeric forms of DN6b 2 m and WT b 2 m (Fig. 5A and S1A ), demonstrating that monomeric forms of b 2 m are also cytotoxic at this concentration.
Next we investigated whether b 2 m could contribute to bone and joint destruction in DRA by reducing the viability of osteoblasts and chondrocytes, the cells that produce bone and cartilage respectively. The association of TMR-labelled DN6b 2 m monomer or b 2 m fibrils with primary human osteoblasts and chondrocytes was visualized by confocal microscopy. After 24 hours, monomeric TMR-labelled DN6b 2 m was present in punctate intracellular structures in osteoblasts and chondrocytes, consistent with internalisation of the protein (Fig. S2A and S3A ). Similar internalization was seen when b 2 m fibrils were incubated with chondrocytes, while fibrils added to osteoblasts remained in close proximity to the cell surface as large aggregates, with some limited cell-associated punctate fluorescence indicative of cell association and internalization (Fig. S2A and S3A ). Our observations suggest both cell types internalize monomeric b 2 m, although chondrocytes internalize b 2 m-fibrils more readily than osteoblasts.
The effect of b 2 m monomer and fibrils on osteoblast and chondrocyte viability was then assessed; both 10 and 100 mg/ml b 2 m fibrils caused a significant reduction in the viability of osteoblasts and chondrocytes (Fig. 5C, 5E , S2B and S3B). DN6b 2 m monomer also reduced cell viability of both cell types (Fig. 5C, 5E , S2B and S3B). In contrast to monomeric DN6b 2 m, 100 mg/ml of WT b 2 m monomer had no significant effect on chondrocyte viability and caused only a limited decrease in viability of osteoblasts, at the highest concentration used (Fig. 5D  and F) . Taken together, these data suggest that monomeric DN6b 2 m and fibrillar b 2 m cytotoxicity to chondrocytes and osteoblasts are important factors in the pathology of DRA. Chondrocyte cell death would be predicted to decrease formation of new cartilage, while the reduction in osteoclast formation in combination with the death of osteoblasts may impair bone turnover in subjects with DRA.
Discussion
Despite the identification of b 2 m as the culprit protein of DRA in 1985 [4, 5] , how b 2 m amyloid causes bone and joint destruction in DRA remains poorly understood. In order to elucidate the cellular basis for the pathological consequences in DRA we performed a systematic analysis of the effects of b 2 m fibrils and monomeric b 2 m on cell types that are present in the synovial joints of subjects with DRA. Our data suggest that the bone and joint destruction characteristic of DRA is a multifactorial process in which b 2 m amyloid fibrils and elevated concentrations of monomeric b 2 m are cytotoxic to multiple cellular targets (Fig. 6) .
We demonstrate that primary human monocytes internalize, but do not degrade, b 2 m fibrils. This is consistent with the resistance of the b 2 m amyloid fold to lysosomal proteolysis [40, 41] , but could be exacerbated by the cytotoxicity of b 2 m fibrils to the monocytic precursors of macrophages. The death of macrophages that infiltrate amyloid deposits in vivo [20] [21] [22] 37] , would be predicted to prevent the clearance of b 2 m monomer and fibrils allowing the continued accumulation of b 2 m amyloid in the synovial joints.
Cells of the monocytic lineage are also the precursors of osteoclasts, which in combination with osteoblasts are responsible for bone remodelling [26] . Monomeric b 2 m did not promote osteoclast formation from human monocytes. This contrasts with a recent study in which monomeric b 2 m was shown to promote osteoclast formation from murine macrophages [28] , and implies that b 2 m has differential effects on human and mouse cells. Similarly, b 2 m fibrils did not promote the formation of bone resorbing osteoclasts despite increased expression of TRAP, as there was no increase in the number of multinucleate cells nor did b 2 m fibrils promote the resorption of the artificial bone substrate. Once considered just as a marker of osteoclasts, it has become clear that TRAP has a number of important roles in both the skeleton and the immune system, and is expressed by a number of different cell types including macrophages [39, 42] . Thus the increase in TRAP expression in monocytes may be the result of the activation of these cells by b 2 m fibrils. Moreover, we found that b 2 m fibrils impaired RANKL-induced osteoclast formation. This was presumably as a consequence of cytotoxicity to monocytes, as fibril-induced cell death of the monocytic precursors would be predicted to prevent these cells from fusing together to form multinucleate osteoclasts. This reduction in osteoclast formation, in combination with the reduction in viability of osteoblasts caused by b 2 m fibrils and to a lesser extent monomeric b 2 m, suggests that bone remodelling will be perturbed in DRA. The formation of bone cysts in DRA may, therefore, be the consequence of a reduction in the turnover of damaged bone, rather than an increase in osteoclast activity. Moreover, the effect of b 2 m fibrils on osteoclast formation and the viability of osteoblasts may exacerbate the reduction in bone turnover that is a common feature of renal osteodystrophy associated with chronic kidney disease [43] . b 2 m fibrils were also shown to be cytotoxic to chondrocytes, rationalizing why the formation of b 2 m amyloid deposits in cartilage results in the loss of this tissue [2, 3, 8, 9, 22] , which could in turn expose the bone surface to the cytotoxic effects of amyloid deposits.
The mechanism by which b 2 m fibrils kill cells is unknown, although other amyloid fibrils have been reported to cause both necrotic and apoptopic cell death [44] [45] [46] . b 2 m fibrils disrupt purified lipid membranes [29] suggesting a role for membrane disruption in fibril-associated cytotoxicity. Since b 2 m fibrils were visualized in association with monocytes, osteoblasts and chondrocytes in proximity to the plasma membrane and within intracellular punctate structures, b 2 m fibrils could kill these cells by disrupting the plasma membrane and/or intracellular membranes. No immunoreactivity was detected by the antibody A11, which recognises amyloid oligomers [32] . This suggests that cytotoxicity associated with b 2 m fibril preparation is mediated by the interaction of b 2 m fibrils with the cells.
Incubation of cells with monomeric WT b 2 m or DN6b 2 m also resulted in reduced viability, with the DN6b 2 m monomer exhibiting the greatest degree of cytotoxicity. While, no oligomers were detected in either protein preparation as determined by SEC and by immunoblotting with the oligomer specific antibody A11, WT b 2 m can form cytotoxic non-fibrillar aggregates [47, 48] , whereas the cytotoxicity of DN6b 2 m could reflect the increased propensity of this truncation to aggregate or its different conformational properties [12, 13, [15] [16] [17] [18] . Although elevated concentrations of WT b 2 m are characteristic of DRA [2, 3, 7] , the relevance of non-fibrillar DN6b 2 m cytotoxicity is unclear, as DN6b 2 m has only been detected in amyloid deposits and is not found in the serum of hemodialysis patients [15, 49] . DN6b 2 m, however, has an increased affinity for collagen [50] , which could lead to localized high concentrations of the soluble protein and resultant cytotoxicity.
The study outlined herein examined how monomeric and fibrillar b 2 m affect primary human cells present in the osteoarticular tissues of subjects with DRA. We have shown previously that b 2 m fibrils are cytotoxic to the murine macrophage RAW 264.7 and human neuroblastoma SH-SY5Y cell lines [29] , demonstrating that b 2 m fibril-associated cytotoxicity is not unique to monocytes, osteoblasts and chondrocytes. Furthermore, since fibrillar preparations of other amyloidogenic precursors are also cytotoxic [29, [44] [45] [46] [51] [52] [53] [54] , it is likely that these would reduce viability of monocytes, osteoblasts and chondrocytes. Amyloid deposits in the osteoarticular tissues can be present in other amyloid diseases [55, 56] and may cause the death of osteoblasts and chondrocytes. Macrophages and macrophage-like cells such as microglia are found in association with other forms of amyloid [57, 58] . As such fibril-associated cytotoxicity to macrophages and macrophage-like cells could be a factor in other amyloid diseases. In conclusion, our observations show that cytotoxicity of monomeric b 2 m and b 2 m fibrils to cell types in the joints of subjects with DRA could be important factors in the development of the osteoarticular pathology of this disorder (Fig. 6 ).
Materials and Methods

Ethics statement
The procedure for the isolation of monocytes from peripheral blood of healthy volunteers was approved by the Faculty of Biological Sciences Research Ethics Committee at the University of Leeds. Written informed consent was given by each donor.
Expression, purification and labelling of b 2 m
Recombinant WT b 2 m and DN6b 2 m were expressed in E. coli and purified as described previously [12, 30, 31] . Purification was confirmed by electrospray ionization mass spectrometry and size exclusion chromatography, as previously described [17] . Endotoxins were removed using an ''EndoTrap Red'' column (Hyglos, Bernreid, Germany) and Limulus amoebocyte lysate assays performed by Lonza (Verviers, Belgium) showed endotoxin concentrations to be #7.35 EU/mg protein. Purified proteins were labelled with TMR (Molecular Probes, Eugene, OR, USA) using methods described previously [40] . Further details are provided in File S1.
Generation of b 2 m fibrils at physiological pH
Fibrils formed at pH 2 [29] were fragmented by freezing in liquid nitrogen and thawing at 37uC three times to generate fibril seeds. 5% (v/v) seeds were elongated with 1 mg/ml DN6b 2 m in Dulbecco's Phosphate Buffered Saline (PBS) pH 7.3, at 37uC, with agitation at 200 rpm in the presence of 0.1 mg/ml low molecular weight heparin (Sigma-Aldrich H8537), 100 U/ml penicillin and 100 mg/ml streptomycin, for 21 days. To generate labelled fibrils, seeds were extended with 0.9 mg/ml unlabelled DN6b 2 m and 0.1 mg/ml TMR-DN6b 2 m. Fibril concentrations are stated as monomer equivalents.
TEM, thioflavin-T binding and immunoblotting
Negative stain TEM and thioflavin-T assays were performed as previously described [17, 30] . Immunoblotting with A11 and WO1 antibodies was performed as described previously [32, 33, 59] , and in detail in File S1.
Isolation and culture of primary human monocytes
Mononuclear cells were isolated from peripheral blood by centrifugation over Lymphoprep (Axis-Shield, Oslo, Norway), monocytes were enriched using the MACS monocyte II kit (Miltenyi Biotec, Bergisch Gladbach, Germany) and enrichment confirmed by flow cytometric analysis of cells stained with anti-CD14-Phycoerythrin (Miltenyi Biotec) on a FACSCalibur instrument (BD Biosciences). Monocytes were cultured at 500 000 cells/ cm 2 , in aMEM supplemented with 10% (v/v) fetal bovine serum (Biosera, Ringmer, UK), 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin and 750 ng/ml M-CSF (Peprotech, Rocky Hill, NJ, USA), at 37uC, 5% CO 2 .
Culture of primary human chondrocytes and osteoblasts
Primary human osteoblasts, chondrocytes, cell specific media and an optimized cell detach kit were obtained from PromoCell (Heidelberg, Germany). Cells were cultured at 10 000-20 000 cells/cm 2 , in cell specific media supplemented with 100 U/ml penicillin and 100 mg/ml streptomycin at 37uC, 5% CO 2 . Cells were passaged a maximum of three times.
MTT assay of cell viability
Cells were plated in 96 well plates (Corning Inc., Corning, NY, USA) and cultured overnight. MTT assays were then performed as described previously [29] and in File S1. For each cell type MTT assays were performed using the same culture conditions, enabling each experiment to be internally controlled to exclude any effects of the growth medium on the reduction of MTT.
Imaging of b 2 m internalization and degradation
Uptake of 10 mg/ml DN6b 2 m monomer (90% unlabelled, 10% TMR labelled) or TMR-DN6b 2 m fibrils over 24 hours, and degradation over a further 24 hours was analyzed using methods described previously [40] and in detail in File S1.
Osteoclast formation and characterization
Primary human monocytes were cultured in 96 well plates (Corning) or on 16 well osteologic slides (BD Biosciences). Osteoclast formation was assessed after 14 days by staining for TRAP and counterstaining with hematoxylin, using a leukocyte acid phosphatase (TRAP) kit (Sigma-Aldrich 387A) and manufacturer's protocol, and by quantifying the percentage resorption of the osteologic substrate. Further details are provided in File S1. 
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